RIPPLY2

gene
On this page

Also known as dJ237I15.1

Summary

RIPPLY2 (ripply transcriptional repressor 2, HGNC:21390) is a protein-coding gene on chromosome 6q14.2, encoding Protein ripply2 (Q5TAB7). Plays a role in somitogenesis.

This gene encodes a nuclear protein that belongs to a novel family of proteins required for vertebrate somitogenesis. Members of this family have a tetrapeptide WRPW motif that is required for interaction with the transcriptional repressor Groucho and a carboxy-terminal Ripply homology domain/Bowline-DSCR-Ledgerline conserved region required for transcriptional repression. Null mutant mice die soon after birth and display defects in axial skeleton segmentation due to defective somitogenesis. Alternative splicing results in multiple transcript variants.

Source: NCBI Gene 134701 — RefSeq curated summary.

At a glance

  • Gene–disease (curated): spondylocostal dysostosis 6, autosomal recessive (Strong, GenCC) — +1 more curated relationship
  • Clinical variants (ClinVar): 103 total — 1 likely-pathogenic
  • Phenotypes (HPO): 43
  • MANE Select transcript: NM_001009994

Identifiers

Gene identifiers

FieldValue
HGNC IDHGNC:21390
Approved symbolRIPPLY2
Nameripply transcriptional repressor 2
Location6q14.2
Locus typegene with protein product
StatusApproved
AliasesdJ237I15.1
Ensembl geneENSG00000203877
Ensembl biotypeprotein_coding
OMIM609891
Entrez134701

Gene structure

Transcript identifiers

Ensembl transcripts: 3 — 2 protein_coding, 1 retained_intron

ENST00000369687, ENST00000369689, ENST00000635617

RefSeq mRNA: 3 — MANE Select: NM_001009994 NM_001009994, NM_001400899, NM_001400900

CCDS: CCDS34493

Canonical transcript exons

ENST00000369689 — 4 exons

ExonStartEnd
ENSE000014506398385724283857515
ENSE000014506418385369583853773
ENSE000014506428385336083853511
ENSE000037550448385409783854161

Expression profiles

Bgee: expression breadth ubiquitous, 146 present calls, max score 89.99.

FANTOM5 (CAGE): breadth broad, TPM avg 1.2954 / max 67.0052, expressed in 216 samples.

FANTOM5 promoters (2 alternative TSS)

Promoter IDTPM avgSamples expressed
687801.2329210
2040870.062544

Top tissues by expression

239 total, by Bgee expression score (0-100, higher = more expressed):

TissueAnatomy IDExpression scoreQuality
cerebellar hemisphereUBERON:000224589.99gold quality
cerebellar cortexUBERON:000212989.85gold quality
right hemisphere of cerebellumUBERON:001489089.78gold quality
Brodmann (1909) area 9UBERON:001354089.53gold quality
cerebellumUBERON:000203788.86gold quality
prefrontal cortexUBERON:000045187.78gold quality
male germ line stem cell (sensu Vertebrata) in testisCL:0000089 ∩ UBERON:000047386.61gold quality
nucleus accumbensUBERON:000188286.26gold quality
dorsolateral prefrontal cortexUBERON:000983486.22gold quality
anterior cingulate cortexUBERON:000983586.10gold quality
right frontal lobeUBERON:000281085.51gold quality
putamenUBERON:000187485.13gold quality
caudate nucleusUBERON:000187384.52gold quality
hypothalamusUBERON:000189884.10gold quality
frontal cortexUBERON:000187084.01gold quality
neocortexUBERON:000195083.49gold quality
amygdalaUBERON:000187682.80gold quality
C1 segment of cervical spinal cordUBERON:000646982.41gold quality
cerebral cortexUBERON:000095682.30gold quality
brainUBERON:000095582.24gold quality
forebrainUBERON:000189082.02gold quality
spinal cordUBERON:000224080.43gold quality
adenohypophysisUBERON:000219680.16gold quality
Ammon’s hornUBERON:000195479.96gold quality
pituitary glandUBERON:000000779.86gold quality
substantia nigraUBERON:000203879.80gold quality
cortical plateUBERON:000534379.48gold quality
midbrainUBERON:000189177.61gold quality
temporal lobeUBERON:000187177.28gold quality
islet of LangerhansUBERON:000000675.73gold quality

Single-cell (SCXA)

Detected in 1 experiment(s), a significant marker in 0.

ExperimentMarker?Max mean expression
E-ANND-3no2.94

Regulation

Is transcription factor: no

Upstream regulators (CollecTRI, top): MESP2

miRNA regulators (miRDB)

12 targeting RIPPLY2, top 30 by miRDB confidence (max_score; target_count = how many genes the miRNA targets in total — lower means more specific):

miRNAMax scoreAvg scoremiRNA target_count
HSA-LET-7A-3P100.0074.033932
HSA-LET-7B-3P100.0074.083913
HSA-LET-7F-1-3P100.0074.023928
HSA-MIR-98-3P100.0074.083907
HSA-MIR-190A-3P100.0080.355520
HSA-MIR-5692A100.0074.406850
HSA-MIR-4666A-3P99.9671.713434
HSA-MIR-381-3P99.9371.872854
HSA-MIR-30099.9271.762856
HSA-MIR-4477A98.8369.752952
HSA-MIR-6771-3P98.2066.53971
HSA-MIR-320197.1665.421044

Literature-anchored findings (GeneRIF, showing 4)

  • Compares Ripply proteins in zebrafish, mouse, human, and amphioxus. (PMID:16326386)
  • Functional analysis of the mouse Ripply2 ortholog. (PMID:17531978)
  • Congenital posterior cervical spine malformation due to biallelic c.240-4T>G RIPPLY2 variant: A discrete entity. (PMID:32212228)
  • Congenital cervical spine malformation due to bi-allelic RIPPLY2 variants in spondylocostal dysostosis type 6. (PMID:33410135)

Cross-species orthologs

3 orthologs

OrganismSymbolGene ID
danio_rerioripply1ENSDARG00000054103
mus_musculusRipply2ENSMUSG00000047897
rattus_norvegicusRipply2ENSRNOG00000010004

Paralogs (2): RIPPLY1 (ENSG00000147223), RIPPLY3 (ENSG00000183145)

Protein

Protein identifiers

Protein ripply2Q5TAB7 (reviewed: Q5TAB7)

All UniProt accessions (1): Q5TAB7

UniProt curated annotations — full annotation on UniProt →

Function. Plays a role in somitogenesis. Required for somite segregation and establishment of rostrocaudal polarity in somites.

Subcellular location. Nucleus.

Disease relevance. Spondylocostal dysostosis 6, autosomal recessive (SCDO6) [MIM:616566] A form of spondylocostal dysostosis, a condition of variable severity associated with vertebral and rib segmentation defects. The main skeletal malformations include fusion of vertebrae, hemivertebrae, fusion of certain ribs, and other rib malformations. Deformity of the chest and spine (severe scoliosis, kyphoscoliosis and lordosis) is a natural consequence of the malformation and leads to a dwarf-like appearance. As the thorax is small, infants frequently have respiratory insufficiency and repeated respiratory infections resulting in life-threatening complications in the first year of life. The disease is caused by variants affecting the gene represented in this entry.

Domain organisation. The ripply homology domain is required for transcriptional repression. The WRPW motif is required for binding to tle/groucho proteins.

Similarity. Belongs to the ripply family.

Isoforms (2)

UniProt IDNamesCanonical?
Q5TAB7-11yes
Q5TAB7-22

RefSeq proteins (3): NP_001009994, NP_001387828, NP_001387829 (=MANE)

Domains & families (InterPro)

IDNameType
IPR028127Ripply_famFamily

Pfam: PF14998

UniProt features (6 total): region of interest 2, chain 1, short sequence motif 1, compositionally biased region 1, splice variant 1

Structure

Experimental structures (PDB)

0 structures.

Predicted structure (AlphaFold)

ModelpLDDTFraction very-high
AF-Q5TAB7-F162.670.07

Function

Pathways and Gene Ontology

Reactome pathways

1 pathways

IDPathway
R-HSA-9824272Somitogenesis

MSigDB gene sets: 146 (showing top): GOBP_EMBRYO_DEVELOPMENT_ENDING_IN_BIRTH_OR_EGG_HATCHING, GOBP_EPITHELIUM_DEVELOPMENT, BENPORATH_ES_WITH_H3K27ME3, GOBP_AXIS_SPECIFICATION, GOBP_SKELETAL_SYSTEM_DEVELOPMENT, GOBP_EMBRYONIC_AXIS_SPECIFICATION, GOBP_SPECIFICATION_OF_SYMMETRY, GOBP_ANIMAL_ORGAN_MORPHOGENESIS, GOBP_BONE_DEVELOPMENT, GOBP_ANTERIOR_POSTERIOR_PATTERN_SPECIFICATION, GOBP_EMBRYONIC_PATTERN_SPECIFICATION, GOBP_SOMITOGENESIS, GOBP_SEGMENTATION, GOBP_OSSIFICATION, GOBP_ANTERIOR_POSTERIOR_AXIS_SPECIFICATION

GO Biological Process (11): negative regulation of transcription by RNA polymerase II (GO:0000122), ossification (GO:0001503), somitogenesis (GO:0001756), Notch signaling pathway (GO:0007219), determination of left/right symmetry (GO:0007368), embryonic pattern specification (GO:0009880), somite rostral/caudal axis specification (GO:0032525), post-anal tail morphogenesis (GO:0036342), bone morphogenesis (GO:0060349), axis specification (GO:0009798), regulation of gene expression (GO:0010468)

GO Molecular Function (1): protein binding (GO:0005515)

GO Cellular Component (1): nucleus (GO:0005634)

Reactome top-level categories

Rollup of top-1 pathways:

CategoryPathways
Formation of paraxial mesoderm1

GO top-level categories

Rollup of top GO terms by namespace:

CategoryTerms
pattern specification process2
regulation of transcription by RNA polymerase II1
transcription by RNA polymerase II1
negative regulation of DNA-templated transcription1
multicellular organismal process1
anterior/posterior pattern specification1
segmentation1
chordate embryonic development1
anatomical structure formation involved in morphogenesis1
somite development1
cell surface receptor signaling pathway1
determination of bilateral symmetry1
left/right pattern formation1
embryo development1
embryonic axis specification1
somitogenesis1
anterior/posterior axis specification1
anatomical structure morphogenesis1
animal organ morphogenesis1
skeletal system morphogenesis1
bone development1
gene expression1
regulation of macromolecule biosynthetic process1
binding1
intracellular membrane-bounded organelle1

Protein interactions and networks

STRING

474 interactions, top by confidence (×1000):

Protein AProtein BPartner UniProtScore
RIPPLY2MESP2Q0VG99807
RIPPLY2TBX6O95947750
RIPPLY2MSGN1A6NI15590
RIPPLY2MEOX1P50221576
RIPPLY2LFNGQ8NES3571
RIPPLY2UNCXA6NJT0532
RIPPLY2CYB5R4Q7L1T6479
RIPPLY2TBX18O95935460
RIPPLY2DLL3Q9NYJ7447
RIPPLY2DLL1O00548425
RIPPLY2CEP162Q5TB80413
RIPPLY2SYNDIG1LA6NDD5411
RIPPLY2MTCL3Q5TF21408
RIPPLY2C6orf163Q5TEZ5398
RIPPLY2PABIR3Q6P4D5395

IntAct

52 interactions, top by confidence:

ABTypeScore
RIPPLY2KASH5psi-mi:“MI:0915”(physical association)0.790
KASH5RIPPLY2psi-mi:“MI:0915”(physical association)0.790
PBX2RIPPLY2psi-mi:“MI:0915”(physical association)0.630
RIPPLY2PBX2psi-mi:“MI:0915”(physical association)0.630
TFGRIPPLY2psi-mi:“MI:0915”(physical association)0.560
RIPPLY2SYNE4psi-mi:“MI:0915”(physical association)0.560
RIPPLY2TFGpsi-mi:“MI:0915”(physical association)0.560
SYNE4RIPPLY2psi-mi:“MI:0915”(physical association)0.560
RIPPLY2PBX4psi-mi:“MI:0915”(physical association)0.560
AVPI1RIPPLY2psi-mi:“MI:0915”(physical association)0.560
C3orf36RIPPLY2psi-mi:“MI:0915”(physical association)0.560
NDUFB7RIPPLY2psi-mi:“MI:0915”(physical association)0.560
RIPPLY2GOLM1psi-mi:“MI:0915”(physical association)0.560
ELAVL4RIPPLY2psi-mi:“MI:0915”(physical association)0.560
RIPPLY2SPRED1psi-mi:“MI:0915”(physical association)0.560
HTTRIPPLY2psi-mi:“MI:0915”(physical association)0.560

BioGRID (30): RIPPLY2 (Two-hybrid), CCDC155 (Two-hybrid), SYNE4 (Two-hybrid), TLE4 (Affinity Capture-MS), TLE2 (Affinity Capture-MS), AES (Affinity Capture-MS), TLE3 (Affinity Capture-MS), TLE1 (Affinity Capture-MS), TRIP6 (Affinity Capture-MS), USP4 (Affinity Capture-MS), RBM23 (Affinity Capture-MS), FERMT2 (Affinity Capture-MS), EXOG (Affinity Capture-MS), CCDC155 (Two-hybrid), RIPPLY2 (Two-hybrid)

ESM2 similar proteins: B1H3B4, B7XDF1, D3ZDX9, D6RGH6, F1SLM8, G3N1S4, O35144, P07516, P18302, P57055, Q0D2K3, Q0II70, Q0X0E2, Q14684, Q14DQ1, Q15554, Q2KI80, Q2WG76, Q2WG78, Q3TVI4, Q3U0L2, Q3UZ45, Q4KLY2, Q5FVJ4, Q5R8C5, Q5RA50, Q5T7N3, Q5TAB7, Q5XKK7, Q60829, Q6J4I0, Q6PJ61, Q7TNF9, Q86V42, Q8BFW3, Q8BRJ3, Q8C4S8, Q8IWP9, Q8NC24, Q8NE31

Diamond homologs: B1H3B4, B7XDF1, P57055, Q0D2K3, Q25QX6, Q2WG76, Q2WG77, Q2WG78, Q2WG79, Q2WG80, Q5I2D0, Q5TAB7, Q8QGU6, Q924S9

SIGNOR signaling

0 interactions.

Disease & clinical

Clinical variants and AI predictions

ClinVar

103 variants total. Per-class counts are floors (≥ shown; pagination cap):

ClassificationCount (floor)
Pathogenic0
Likely pathogenic1
Uncertain significance57
Likely benign36
Benign8

Top pathogenic / likely-pathogenic (1)

Variant IDHGVSClassification
218314NM_001009994.3(RIPPLY2):c.299del (p.Leu100fs)Likely pathogenic

SpliceAI

724 predictions. Top by Δscore:

VariantEffectΔscore
6:83853980:GCTGC:Gdonor_gain1.0000
6:83853509:CGGGT:Cdonor_loss0.9900
6:83853510:GG:Gdonor_gain0.9900
6:83853510:GGGT:Gdonor_loss0.9900
6:83853511:GG:Gdonor_gain0.9900
6:83853511:GGT:Gdonor_loss0.9900
6:83853512:G:GAdonor_loss0.9900
6:83853512:G:GGdonor_gain0.9900
6:83853513:TAGGC:Tdonor_loss0.9900
6:83853770:GGCG:Gdonor_gain0.9900
6:83853771:GCG:Gdonor_gain0.9900
6:83853771:GCGG:Gdonor_gain0.9900
6:83853774:G:GGdonor_gain0.9900
6:83853972:G:GTdonor_gain0.9900
6:83854091:CTCCA:Cacceptor_loss0.9900
6:83854092:TCCAG:Tacceptor_loss0.9900
6:83854093:CCAG:Cacceptor_loss0.9900
6:83854094:CA:Cacceptor_loss0.9900
6:83854095:A:AGacceptor_gain0.9900
6:83854095:A:Gacceptor_loss0.9900
6:83854096:G:Aacceptor_loss0.9900
6:83854096:G:GGacceptor_gain0.9900
6:83854132:A:Tdonor_gain0.9900
6:83854157:GTCAG:Gdonor_gain0.9900
6:83854159:CAG:Cdonor_loss0.9900
6:83854160:AGGTG:Adonor_loss0.9900
6:83854161:GG:Gdonor_loss0.9900
6:83854162:GT:Gdonor_loss0.9900
6:83854163:TGAG:Tdonor_loss0.9900
6:83854839:G:GTdonor_gain0.9900

AlphaMissense

828 scored. Top likely-pathogenic:

VariantProtein changeam_pathogenicity
6:83857328:T:AI109N0.997
6:83857328:T:CI109T0.996
6:83857328:T:GI109S0.996
6:83857301:T:CL100P0.994
6:83857249:T:AW83R0.991
6:83857249:T:CW83R0.991
6:83857251:G:CW83C0.991
6:83857251:G:TW83C0.991
6:83854158:T:AV79D0.990
6:83857321:G:CA107P0.990
6:83857322:C:AA107D0.989
6:83857298:T:CL99P0.987
6:83857310:T:CF103S0.987
6:83854153:C:AH77Q0.985
6:83854153:C:GH77Q0.985
6:83857244:T:CL81P0.985
6:83853713:A:CR38S0.984
6:83853713:A:TR38S0.984
6:83854151:C:GH77D0.984
6:83857320:A:CQ106H0.984
6:83857320:A:TQ106H0.984
6:83857277:T:CL92S0.983
6:83857301:T:AL100Q0.983
6:83857330:T:CS110P0.983
6:83854152:A:GH77R0.982
6:83857288:G:CA96P0.982
6:83857279:T:GY93D0.979
6:83857250:G:CW83S0.978
6:83853717:T:AW40R0.977
6:83853717:T:CW40R0.977

dbSNP variants (sampled 300 via entrez): RS1000510704 (6:83855215 C>A,G,T), RS1000870904 (6:83852271 G>A), RS1002119759 (6:83854912 T>C), RS1002334331 (6:83855040 C>G), RS1002592659 (6:83853278 G>A), RS1002667414 (6:83854559 A>T), RS1002843085 (6:83854607 A>G), RS1003310971 (6:83856307 A>C), RS1003794154 (6:83856891 G>A,T), RS1003990488 (6:83856054 T>TA), RS1004063959 (6:83856347 C>G,T), RS1005795896 (6:83856246 T>A), RS1006071990 (6:83853259 T>G), RS1006243106 (6:83856589 T>C), RS1006542329 (6:83857945 C>A)

Disease associations

OMIM: gene MIM:609891 | disease phenotypes: MIM:616566, MIM:214300

GenCC curated gene-disease

DiseaseClassificationInheritance
spondylocostal dysostosis 6, autosomal recessiveStrongAutosomal recessive
autosomal recessive spondylocostal dysostosisSupportiveAutosomal recessive

Mondo (3): spondylocostal dysostosis 6, autosomal recessive (MONDO:0014694), Klippel-Feil syndrome 2, autosomal recessive (MONDO:0008958), autosomal recessive spondylocostal dysostosis (MONDO:0010180)

Orphanet (2): Autosomal recessive spondylocostal dysostosis (Orphanet:2311), Isolated Klippel-Feil syndrome (Orphanet:2345)

HPO phenotypes

43 total (30 of 43 shown, HPO-id order):

HPOTerm
HP:0000007Autosomal recessive inheritance
HP:0000008Abnormal morphology of female internal genitalia
HP:0000023Inguinal hernia
HP:0000028Cryptorchidism
HP:0000047Hypospadias
HP:0000069Abnormality of the ureter
HP:0000175Cleft palate
HP:0000252Microcephaly
HP:0000256Macrocephaly
HP:0000269Prominent occiput
HP:0000337Broad forehead
HP:0000343Long philtrum
HP:0000358Posteriorly rotated ears
HP:0000463Anteverted nares
HP:0000470Short neck
HP:0000772Abnormal rib morphology
HP:0000776Congenital diaphragmatic hernia
HP:0000902Rib fusion
HP:0001249Intellectual disability
HP:0001511Intrauterine growth retardation
HP:0001537Umbilical hernia
HP:0002093Respiratory insufficiency
HP:0002435Meningocele
HP:0002650Scoliosis
HP:0002808Kyphosis
HP:0002937Hemivertebrae
HP:0002947Cervical kyphosis
HP:0003298Spina bifida occulta
HP:0003312Abnormal form of the vertebral bodies
HP:0003316Butterfly vertebrae

GWAS associations

0 associations (top):

MeSH disease descriptors (2)

DescriptorNameTree numbers
C536888Klippel Feil syndrome recessive type (supp.)
C535781Spondylocostal dysostosis, autosomal recessive (supp.)

Drugs & pharmacology

Drug and pharmacology data

Is drug target: no

PharmGKB: 1 entry (VIP=true, CPIC=false)

CTD chemical–gene interactions

11 total (human), top 11 by PubMed support.

ChemicalActions (top 5)PubMed papers
N(4)-hydroxycytidinedecreases expression1
decabromobiphenyl etheraffects expression1
arseniteincreases methylation1
butyraldehydeincreases expression1
(+)-JQ1 compounddecreases expression1
Sunitinibdecreases expression1
Acetaminophenincreases expression1
Benzo(a)pyreneincreases methylation1
Smokedecreases expression1
Tobacco Smoke Pollutionincreases expression1
Cadmium Chloridedecreases expression1

Clinical trials (associated diseases)

0 trials via MONDO — disease-level, not drug-specific.